CIK 0001464521 · <br>Emerging growth company
Heartflow, Inc.
Sign in to watch- Ticker
- HTFL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260506743
- Phone
- 650-241-1221
- Business address
- 135 MAIN STREET, SUITE 1000, SAN FRANCISCO, CA, 94105
- Former names
- Cardiovascular Simulation, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,602,722
- in 13 filings, $16.6M under 10b5-1 plans
Net −$16,602,722. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-06 | Farquhar John C.M. Chief Executive Officer | Grant or award 10b5-1 | +2,631 | $16.15 | $42K | 594,287 |
| 2026-03-05 | Cullivan Julie A Director | Sale 10b5-1 | −9,122 | $25.00 | $228K | 27,291 |
| 2026-02-17 | BARABE TIMOTHY C Director | Option exercise | +2,497 | $8.33 | $21K | 170,854 |
| 2026-02-17 | BARABE TIMOTHY C Director | Option exercise · Stock Option | −2,497 | 0 | ||
| 2026-02-12 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +19,401 | $2.22 | $43K | 93,572 |
| 2026-02-12 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +39,709 | $8.33 | $331K | 133,281 |
| 2026-02-12 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +7,906 | $2.22 | $18K | 141,187 |
| 2026-02-12 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −65,153 | $24.49 | $1.6M | 76,034 |
| 2026-02-12 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −39,709 | 0 | ||
| 2026-02-12 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −19,401 | 216,433 | ||
| 2026-02-12 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Option 10b5-1 | −7,906 | 208,527 | ||
| 2026-02-10 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −22,562 | $27.46 | $620K | 591,656 |
| 2026-02-06 | Jones Marie L. Chief Accounting Officer, VP | Shares withheld for taxes | −94 | $27.74 | $3K | 10,021 |
| 2026-02-06 | Jones Marie L. Chief Accounting Officer, VP | Grant or award | +21,629 | 31,650 | ||
| 2026-02-06 | Jones Marie L. Chief Accounting Officer, VP | Grant or award · Stock Option | +37,795 | 37,795 | ||
| 2026-02-06 | Farquhar John C.M. Chief Executive Officer | Shares withheld for taxes 10b5-1 | −1,541 | $27.74 | $43K | 430,368 |
| 2026-02-06 | Farquhar John C.M. Chief Executive Officer | Grant or award 10b5-1 | +183,850 | 614,218 | ||
| 2026-02-06 | Farquhar John C.M. Chief Executive Officer | Grant or award · Stock Option 10b5-1 | +321,259 | 321,259 | ||
| 2026-02-06 | Rogers Campbell Chief Medical Officer | Shares withheld for taxes | −515 | $27.74 | $14K | 20,098 |
| 2026-02-06 | Rogers Campbell Chief Medical Officer | Grant or award | +54,073 | 74,171 |
Page 7 of 12 · 224 trades